Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our
contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future
pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply
contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase
price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other
governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign
government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth
in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures
in European countries that may increase the amount of discount required on Gilead's products; an increase
in discounts, chargebacks and rebates due to ongoing
contracts and future negotiations with commercial and
government payers; a larger than anticipated shift
in payer mix to more highly discounted payer segments and geographic regions and decreases
in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations
in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations
in Gilead's earnings; market share and
price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other
government action that could have the effect of lowering
prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials
in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations
in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates
in the timelines currently anticipated; Gilead's ability to receive regulatory approvals
in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta
in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes
in its stock
price, corporate or other market conditions; fluctuations
in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time
in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Initially, the directors rejected the proposal: They felt it would strain resources, particularly as Tesla was dealing with manufacturing challenges with its Model X. (Separately, a month later, SpaceX purchased $ 90 million worth of bonds from SolarCity, a move that reportedly raised eyebrows
in Washington, with some lawmakers concerned that Musk was using his aerospace venture's high -
priced government contracts to buoy his solar company.)
A possible game changer is the Petro - yuan, the Chinese
government's plans to start a crude oil futures
contract priced in yuan and convertible into gold.
In contrast to IMF loans to support the kleptocrats» banks and new Cold War asset grabs from the Eastern border provinces with Russia, Ukraine's sale of bonds to Russia's sovereign debt fund and its
contracts signed for gas purchases were negotiated by a democratically elected
government, at
prices that subsidized domestic industry and also household consumption.
That this House: (1) notes with concern the impact on the Dairy Industry of the Coles milk
pricing strategy and that: (a) dairy farmers around the country are today seriously questioning their future having suffered through one of the worst decades
in memory including droughts, floods,
price cuts and rising cost of inputs such as energy and feed; (b) unsustainable retail milk
prices will, over time, compel processors to renegotiate
contracts with dairy farmers and the prospect that these
contracts will be below the cost of production may force many to leave the industry; (c) the fact that supermarkets are now selling milk cheaper than many varieties of bottled water will be the straw that finally breaks the camel's back for many dairy farmers; and (d) the risk of other potential impacts includes: (i) decreased competition as name brands are forced from the shelves; and (ii) the possible loss of fresh milk supplies to some parts of the country as local fresh milk industries become unviable; and (2) calls on the
Government to: (a) ask the ACCC to immediately examine the big supermarkets and milk wholesalers after recent
price cuts to ensure they do not have too much market power and are not anti-competitive
in their behaviour; and (b) support the new Senate inquiry into the ongoing milk
price war between the country's major supermarket chains».
German power companies, with the backing of the German
government, made
contracts to deliver pipes for pipelines to the Soviet Union -LRB-... that long ago)
in exchange for preferential gas
prices, and since then both sides have a vital national interest
in a stable, predicatable exchange of gas for money.
He adds that the launch fees that
government agencies pay tend to be negotiated
in long - term
contracts, based on payload needs, and don't necessarily align with
prices published on a company website.
(a) Lay day time will be paid by the
Government at the Contractor's stipulated bid
price for this item of the
contract when the vessel remains on the dry dock or marine railway as a result of any change that involves work
in addition to that required under the basic
contract.
(7) Treat the contents of any tank as
Government property
in accordance with the
Government Property (Fixed -
Price Contracts) clause; and
(3) Treat salvage, scrap or other ship's material of the
Government resulting from performance of the work as items of
Government - furnished property,
in accordance with the
Government Property (Fixed
Price Contracts) clause;
(e) The Contractor shall not make any allowance
in the
contract price for the inclusion of any premium expense or charge for any reserve made on account of self - insurance for coverage against any risk assumed by the
Government under this clause.
UK - based Datawind which had bagged a
contract for supplying low - cost tablet «Aakash» to the
government, Thursday launched two such computing devices
in the
price range of Rs 3,000 - 4,000, considered to be amongst the cheapest
in the market.
In Atlantic Canada, the Newfoundland and Labrador economy was hit hard in 2016 by energy price declines, with the provincial government expecting the province to contract in real terms in 201
In Atlantic Canada, the Newfoundland and Labrador economy was hit hard
in 2016 by energy price declines, with the provincial government expecting the province to contract in real terms in 201
in 2016 by energy
price declines, with the provincial
government expecting the province to
contract in real terms in 201
in real terms
in 201
in 2017.
There are many obstacles that stand
in the way of U.S. breeders being able to easily sell dogs to the
government for detection work, including low - market
price for top - working field - line puppies and complicated
government vendor
contracts that make it difficult for individual breeders.
The «subsidy» could come
in the form of
government - mandated power purchasing
contracts at above market
prices.
SolarReserve has broken a solar
price record with its 20 - year
contract to supply the South Australian
government with dispatchable solar at a levelized cost between $ 75 and $ 78 per megawatt hour (MWh)
in Australian dollars, which itself is a world record low
price for CSP.
The Ontario
government's energy policy, which pays high
prices for renewables
contracts, is actually wasting clean, efficient and reliable power from other sources, says the Ontario Society of Professional Engineers,
in its blog late last week.
The Australian Capital Territory (ACT), represented by Shane Rattenbury, the Minister for Climate and Sustainability, showed how
government action can meet 100 percent renewable energy targets by locking
in long term, fixed -
price renewable
contracts.
So when the
government comes
in and makes a change, or does a deal with a private corporation to come
in and do something, it's really that the people don't have a say it what that
contract looks like or what
price they're going to pay for water, or what access they're going to have.
Mr. McGinnis has defended corporations and individuals
in criminal cases and grand jury matters involving alleged
price - fixing and other anti-competitive conduct, insider trading,
government fraud and defense
contracting fraud, and environmental violations, among other matters.
His articles have been published
in the American Bar Association's Public
Contract Law Journal, the
Government Contract Costs,
Pricing & Accounting Report, and
in the Construction Business Review.
We have substantial expertise
in government accounting, cost allowability, defective
pricing, claims identification and analysis, intellectual property protection, bid protests, debarment and suspension,
contract terminations, and
contract changes.
In addition to representing clients in the commercial nuclear power sector, Morgan Lewis assists the DOE's largest contractors in an array of complex legal, regulatory, contractual, and operational issues, among them labor, employment, wage - hour, and employee benefits counseling; government contracts; environmental regulation; Price - Anderson enforcement support; and nuclear indemnity and liability matter
In addition to representing clients
in the commercial nuclear power sector, Morgan Lewis assists the DOE's largest contractors in an array of complex legal, regulatory, contractual, and operational issues, among them labor, employment, wage - hour, and employee benefits counseling; government contracts; environmental regulation; Price - Anderson enforcement support; and nuclear indemnity and liability matter
in the commercial nuclear power sector, Morgan Lewis assists the DOE's largest contractors
in an array of complex legal, regulatory, contractual, and operational issues, among them labor, employment, wage - hour, and employee benefits counseling; government contracts; environmental regulation; Price - Anderson enforcement support; and nuclear indemnity and liability matter
in an array of complex legal, regulatory, contractual, and operational issues, among them labor, employment, wage - hour, and employee benefits counseling;
government contracts; environmental regulation;
Price - Anderson enforcement support; and nuclear indemnity and liability matters.
The FIT program is a major component of the province's plan to develop green energy and jobs
in Ontario by establishing a
government procurement process for electricity generated from renewable sources with standard program rules, standard
contracts, and standard
pricing.
Summary of Qualifications: 25 plus years of progressively more responsible experience as a senior management team member
in government and commercial to include Vice President of
Contracts and
Pricing to an 8 (a), business development, proposal development,
contract administration, operations and financial support functions.
SUMMARY
Contracts and procurement management executive with considerable experience
in government and commercial
contracting and
pricing.
After spending four years living
in NYC
pricing Government contracts for Booz Allen Hamilton, she headed back home to the DMV.